Navigation Links
Singapore scientists identify new biomarker for cancer in bone marrow
Date:12/13/2012

1. Singapore scientists have identified FAIM, a molecule that typically prevents cell death, as a potential biomarker to identify an incurable form of cancer in the bone marrow. Patients with this form of cancer usually do not get cured with current standard treatments such as chemotherapy and stem cell transplantation, with an average survival of only about four years. FAIM could thus be a therapeutic target in these patients, as drugs developed to target the molecule could destroy multiple myeloma cells and hence eradicate the cancer.

2. Multiple myeloma is an incurable cancer of blood cells, which arises due to an uncontrollable accumulation of antibody-producing plasma cells in the bone marrow. In Singapore, about 80 new cases of multiple myeloma are diagnosed every year. Unfortunately, most people who develop multiple myeloma have no clearly identifiable risk factors for the disease but factors such as individuals older than 50 years of age, men and obesity, may predispose one to the cancer.

3. The scientists discovered that a protein called Fas apoptosis inhibitory molecule (FAIM) can affect the activation of Akt, an important enzyme required for cancer cell proliferation. By silencing the expression of FAIM, the team showed that the myeloma cells could be destroyed. It was also found that this protein was present at higher levels in the plasma cells of these patients as compared to normal individuals, and that higher levels of FAIM correlated to poorer survival outcomes of patients. This is an important breakthrough as it not only identifies FAIM as a useful biomarker of multiple myeloma patients, but also as a good target that drugs can be developed for, in order to get rid of the cancer cells.

4. This collaborative research was conducted by scientists at A*STAR's Bioprocessing Technology Institute (BTI) led by Prof Lam Kong-Peng, along with clinician-scientists at National University Cancer Institute, Singapore (NCIS) and th
'/>"/>

Contact: Vithya Selvam
vithya_selvam@a-star.edu.sg
656-826-6291
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Regular Distributor Conference Calls Planned For Marketing Xocolate International
2. Xocai Mayalsia
3. Xocai Taiwan
4. Xocai Singapore
5. Scientists ID Gene That Shows Progression in ALS Patients
6. Scientists train honey bees to stick out their tongues
7. NIH scientists reflect on gains in emerging infectious disease awareness, research and response
8. 2 UT Southwestern scientists honored as rising stars in Texas research
9. Drug resistant leukemia stem cells may be source of genetic chaos, Temple scientists find
10. UCLA cancer scientists identify liposarcoma tumors that respond to chemotherapy
11. To make old skin cells act young again, boost their surroundings, U-M scientists show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... Tarrytown, NY (PRWEB) March 26, 2015 ... conducted its 30th “Introduction to Hyperbaric Medicine” course, ... Hyperbaric Medical Society (UHMS) and the National Board ... LST provides the 40-hour course 4 times a ... facilities around the NY tri-state region; registration is ...
(Date:3/26/2015)... 26, 2015 On March 5, 2015, ... is out for the season with a torn Achilles ... the Trail Blazers were competing against Dallas, and was ... specialist, Izzy Silva, M.D., who has treated many professional ... whether it could be prevented. , "Part of ...
(Date:3/26/2015)... 2015 Volunteers will collectively walk hundreds ... disease and funds to support the American Parkinson ... – Find the Cure. The Optimism Walk ... in more than 20 locations including, Boston, Chicago, Connecticut, ... Antonio, Minnesota, Seattle, St. Louis, New York, Nevada, South ...
(Date:3/26/2015)... Hartford, CT (PRWEB) March 26, 2015 ... Connecticut State Capitol Building to help celebrate the achievement ... a groundbreaking employment program serving some 500 people. , ... by The WorkPlace in partnership with the ... coach and prepare long-term unemployed workers and place them ...
(Date:3/26/2015)... The beauty industry united on Saturday, March ... revolutionized the business of beauty education. The Beauty Changes ... Pivot Point International, Inc. Passage’s wife Lenie, and son ... at the Art Institute of Chicago, the sold-out event ... media leaders and served as the signature gala event ...
Breaking Medicine News(10 mins):Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 3Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 4Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 2Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 3Health News:Sports Medicine Specialist Weighs In on Wesley Matthew’s Significant Tendon Injury; Can it be Prevented? 4Health News:American Parkinson Disease Association 2015 Optimism Walk Season Launches Nationwide 2Health News:CRN International Shows Support For Groundbreaking Connecticut Program To Aid The Unemployed 2Health News:#BeautyChangesLives Legacy Award Pays Tribute to Industry Icon Leo Passage 2Health News:#BeautyChangesLives Legacy Award Pays Tribute to Industry Icon Leo Passage 3
... replicate damaged DNA could dramatically enhance the effectiveness of ... pair of papers from MIT biologists. In studies ... specific system for tolerating DNA damage not only prolonged ... to chemotherapy, and made tumors much less likely to ...
... health in the eyes of diabetic mice has researchers wanting to ... the same for people. "We want to know if this ... occur with diabetes," said Dr. Sylvia Smith, retinal cell biologist and ... Georgia. "That means we need to know more about how and ...
... is available in French . , A fundamental ... doctors who treat breast cancer, this is easier said than ... breast cancer their treatment usually involves surgery to remove ... cancer returning. But studies show that for most patients with ...
... -- A solar-powered blood-pressure measuring device that,s reliable and affordable ... low-income nations, according to a new study. Field tests ... and one in Zambia -- showed that the $32 automated ... testing method for systolic blood pressure, which is the top ...
... 8 (HealthDay News) -- U.S. physicians, links with drug ... decreased since 2004, but many doctors still have ties ... survey found that about four out of five doctors ... their workplaces and more than 75 percent were given ...
... PICK: PIT(-1)ting good and bad outcomes against each other in ... cancer is determined in part by whether or not their ... team of researchers, led by Roman Perez-Fernandez and colleagues, at ... in a subset of patients with breast cancer, a marker ...
Cached Medicine News:Health News:Massachusetts Institute of Technology IDs new cancer drug target 2Health News:Potential drug therapy for diabetic retinopathy under study 2Health News:Potential drug therapy for diabetic retinopathy under study 3Health News:Breast cancer: Reducing the risk of unnecessary chemo 2Health News:Solar Blood-Pressure Device Shows Promise for Use in Poor Nations 2Health News:Fewer U.S. Docs Accepting Perks From Industry: Survey 2Health News:JCI online early table of contents: Nov. 8, 2010 2Health News:JCI online early table of contents: Nov. 8, 2010 3Health News:JCI online early table of contents: Nov. 8, 2010 4Health News:JCI online early table of contents: Nov. 8, 2010 5
(Date:3/26/2015)... 2015 According to a new ... Technology (RF, Microwave, Cryoablation, Others), Department (Interventional Radiology, Surgery, ... Metastasis) - Global Forecasts to 2019", published by MarketsandMarkets, ... $462.0 Million growing at a CAGR of 11.50% by ... 57 figures spread through 195 pages and in-depth TOC ...
(Date:3/26/2015)... , March 26, 2015  CCS Medical ("CCS"), ... medical supplies for patients with chronic conditions, has ... Chief Executive Officer, effective March 23.  Mr. Carson ... company, where he was President of Operations. ... President and Executive Vice President of Operations at ...
(Date:3/26/2015)... 26, 2015  Desert Valley Medical Center, named a ... is the first U.S. hospital to deploy the ... to help clinicians prevent hospital acquired pressure ulcers. ... , is a community hospital serving some higher ... Leaf Patient Monitor in the hospital,s emergency department enables ...
Breaking Medicine Technology:Tumor Ablation Market Worth $462.0 Million by 2019 2Tumor Ablation Market Worth $462.0 Million by 2019 3Tumor Ablation Market Worth $462.0 Million by 2019 4CCS Medical Team Hires Industry Operator Rodney Carson as CEO 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 3
... landmark trial provide important insight for physicians in treating ... Corporation (NYSE: BSX ) today welcomed the ... this week,s issue of the New England Journal of ... Cardiovascular Research Foundation with research grant support from Boston ...
... over linezolid in resistance acquisition by Staph aureus ... meetingSAN DIEGO, Calif., May 6 Trius Therapeutics, ... the treatment of serious bacterial infections, announced today ... lead program, torezolid (TR-701), will be presented in ...
Cached Medicine Technology:Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine 2Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine 3Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine 4Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine 5Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases 2Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases 3
CritiCool™ offers precise cooling to the programmed target temperature by applying temperature control algorithm....
Inquire...
Whole blood tube use for microbiology...
BD Vacutainer® Specialty Tubes - Other - Glass...
Medicine Products: